WO2003086305A3 - Biodegradable peg-based polymer formulations in ocular applications - Google Patents

Biodegradable peg-based polymer formulations in ocular applications Download PDF

Info

Publication number
WO2003086305A3
WO2003086305A3 PCT/US2003/011061 US0311061W WO03086305A3 WO 2003086305 A3 WO2003086305 A3 WO 2003086305A3 US 0311061 W US0311061 W US 0311061W WO 03086305 A3 WO03086305 A3 WO 03086305A3
Authority
WO
WIPO (PCT)
Prior art keywords
eye
based polymer
polymer formulations
ocular applications
biodegradable peg
Prior art date
Application number
PCT/US2003/011061
Other languages
French (fr)
Other versions
WO2003086305A2 (en
WO2003086305A8 (en
Inventor
Daniel M Schwartz
Keith Duncan
Jay Stewart
Original Assignee
Univ California
Daniel M Schwartz
Keith Duncan
Jay Stewart
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California, Daniel M Schwartz, Keith Duncan, Jay Stewart filed Critical Univ California
Priority to AU2003226059A priority Critical patent/AU2003226059A1/en
Publication of WO2003086305A2 publication Critical patent/WO2003086305A2/en
Publication of WO2003086305A8 publication Critical patent/WO2003086305A8/en
Publication of WO2003086305A3 publication Critical patent/WO2003086305A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/046—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea

Abstract

The present invention relates to methods and pharmaceutical compositions involving the use of bioerodible (biodegradable) polymers to address fundamental needs in ocular surgery including sealants and sealing methods, barriers to cellular adhesion and proliferation, and mechanical barriers. In a particular embodiment, the present invention is also directed to the treatment of intraocular hypotony in an eye by limiting the flow of aqueous from the eye. In a preferred embodiment, application of a polymer, such as to the angle of the eye, limits the flow, thereby increasing the intraocular pressure.
PCT/US2003/011061 2002-04-10 2003-04-10 Biodegradable peg-based polymer formulations in ocular applications WO2003086305A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003226059A AU2003226059A1 (en) 2002-04-10 2003-04-10 Biodegradable peg-based polymer formulations in ocular applications

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37153102P 2002-04-10 2002-04-10
US60/371,531 2002-04-10

Publications (3)

Publication Number Publication Date
WO2003086305A2 WO2003086305A2 (en) 2003-10-23
WO2003086305A8 WO2003086305A8 (en) 2004-02-12
WO2003086305A3 true WO2003086305A3 (en) 2004-03-18

Family

ID=29250696

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/011061 WO2003086305A2 (en) 2002-04-10 2003-04-10 Biodegradable peg-based polymer formulations in ocular applications

Country Status (3)

Country Link
US (1) US20030223957A1 (en)
AU (1) AU2003226059A1 (en)
WO (1) WO2003086305A2 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8288362B2 (en) * 2004-05-07 2012-10-16 S.K. Pharmaceuticals, Inc. Stabilized glycosaminoglycan preparations and related methods
WO2005110397A1 (en) * 2004-05-07 2005-11-24 The Regents Of The University Of California Treatment of myopia
US20050281866A1 (en) * 2004-05-24 2005-12-22 Genzyme Corporation Adherent polymeric compositions
US9393344B2 (en) * 2006-01-11 2016-07-19 Hyperbranch Medical Technology, Inc. Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices
EP1864777B1 (en) * 2006-06-08 2009-09-23 DWI an der RWTH Aachen e.V. Structuring hydrogels
CA2690624A1 (en) * 2007-07-23 2009-01-29 Hyperbranch Medical Technology, Inc. Polymeric masking materials for spanning wound sites, and methods of use thereof
US20090131303A1 (en) * 2007-11-16 2009-05-21 Bor-Shyue Hong Methods and compositions for treating dry eye
US9877973B2 (en) * 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
WO2011017123A2 (en) 2009-07-27 2011-02-10 Endologix, Inc. Stent graft
WO2011140517A2 (en) 2010-05-07 2011-11-10 Medicus Biosciences, Llc Methods for treating diseases of the lung
US10111985B2 (en) 2011-08-10 2018-10-30 Medicus Biosciences, Llc Biocompatible hydrogel polymer formulations for the controlled delivery of biomolecules
US11083821B2 (en) 2011-08-10 2021-08-10 C.P. Medical Corporation Biocompatible hydrogel polymer formulations for the controlled delivery of biomolecules
RU2485919C1 (en) * 2012-04-12 2013-06-27 Федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения и социального развития Российской Федерации Method of medicinal application of cornea with bioplastic material "hyamatrix"
EP2846847B1 (en) * 2012-05-11 2020-03-25 C.P. Medical Corporation Biocompatible hydrogel treatments for retinal detachment
AU2013347897A1 (en) 2012-11-21 2015-07-09 University Of Louisville Research Foundation, Inc Compositions and methods for reducing oxidative damage
JP6516721B2 (en) 2013-03-14 2019-05-22 メディカス バイオサイエンシーズ エルエルシー Biocompatible pre-formulation based on solid polyglycol
ES2727293T3 (en) * 2013-03-14 2019-10-15 Univ Massachusetts Cataract and presbyopia inhibition methods
WO2015102000A2 (en) * 2014-01-02 2015-07-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Ophthalmic viscosurgical device
WO2016130478A1 (en) 2015-02-09 2016-08-18 University Of Louisville Research Foundation, Inc. Ophthalmic compositions and methods for reducing oxidative damage to an eye lens
US10980882B2 (en) * 2015-09-25 2021-04-20 Jennifer J. KANG-MIELER Biodegradable microsphere-hydrogel ocular drug delivery system
US11266608B2 (en) 2015-09-25 2022-03-08 Jennifer J. Kang-Mteler Biodegradable extended release microsphere-hydrogel ocular drug delivery system and method
CR20180294A (en) 2015-11-13 2018-08-10 Univ Massachusetts BIFUNCTIONAL MOLECULES CONTAINING PEG FOR USE IN THE INHIBITION OF CATARATS AND PRESBY
US11752099B2 (en) * 2017-03-27 2023-09-12 W. L. Gore & Associates, Inc. Injectable and biodegradable polymer formulations for controlled release of bioactive agents
JP2022543648A (en) * 2019-08-06 2022-10-13 ドーズ メディカル コーポレーション Bioerodible Crosslinked Hydrogel Implants and Associated Methods of Use
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
JPWO2022092209A1 (en) * 2020-10-29 2022-05-05
EP4291161A1 (en) * 2021-02-09 2023-12-20 The Brigham & Women's Hospital, Inc. Pectin compositions and methods of use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6149931A (en) * 1997-10-27 2000-11-21 The Regents Of The University Of California Methods and pharmaceutical compositions for the closure of retinal breaks

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7009034B2 (en) * 1996-09-23 2006-03-07 Incept, Llc Biocompatible crosslinked polymers
US6566406B1 (en) * 1998-12-04 2003-05-20 Incept, Llc Biocompatible crosslinked polymers

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6149931A (en) * 1997-10-27 2000-11-21 The Regents Of The University Of California Methods and pharmaceutical compositions for the closure of retinal breaks

Also Published As

Publication number Publication date
US20030223957A1 (en) 2003-12-04
AU2003226059A1 (en) 2003-10-27
AU2003226059A8 (en) 2003-10-27
WO2003086305A2 (en) 2003-10-23
WO2003086305A8 (en) 2004-02-12

Similar Documents

Publication Publication Date Title
WO2003086305A8 (en) Biodegradable peg-based polymer formulations in ocular applications
WO2000027887A3 (en) Cross-linked hyaluronic acids and medical uses thereof
DE60331367D1 (en) ACTIVE COMPOSITION OF FAST GELING POLYMERIC COMPOSITION
AR034660A1 (en) NEBULIZER FOR THE APPLICATION OF LIQUIDS ON THE EYE CORNEA
WO2010147864A3 (en) Biomedical devices, polymeric materials and contact lenses comprising the same
TNSN08079A1 (en) Pharmaceutical compositions for the treatment of inner ear disorders
BRPI0711620A2 (en) polymeric mixtures of anionic and cationic polysaccharides and use of these
CY1114048T1 (en) Combination of brimonidine and timolol for topical ophthalmic use
CA2522232A1 (en) Cross-linked polysaccharide composition
WO2006132647A3 (en) Antimicrobial copolymers and uses thereof
WO2005002520A3 (en) Ophthalmic compositions for treating ocular hypertension
CA2453592A1 (en) Dry hemostatic compositions and methods for their preparation
WO2005055924A3 (en) Skin adherent hydrogels
DE60135784D1 (en) THE VISCOSITY OF POLYALKYLENE GLYCOL INCREASING POLYMERS FORMULATIONS
ATE447590T1 (en) CATIONIC HYDROPHILIC SILOXANYL MONOMERS
WO2008073909A3 (en) Use of peo-pbo block copolymers in ophthalmic compositions
WO2007081396A3 (en) Initiators and crosslinkable polymeric materials
WO2005051316A3 (en) Polymer compositions and methods for their use
WO2007010034A3 (en) Ampholytic copolymer, production thereof, and use of the same
WO2006054309A3 (en) Debriding composition from bromelain
WO2007078585A3 (en) High refractive-index siloxy-containing monomers and polymers, and ophthalmic devices comprising such polymers
WO2009064977A3 (en) Dextran-based polymer tissue adhesive for medical use
ATE494333T1 (en) ADHESIVES, PRODUCTION THEREOF AND APPLICATIONS THEREOF
NO20062960L (en) Compositions of Semi-Interpenetrating Polymer Network
DE60319128D1 (en) BIODEGRADABLE POLY (ORTHO ESTERS) OF DI (KETENACETALES) BASED ON DIOXIDE, AS WELL AS BLOCK COPOLYMERS CONTAINING THEM

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 43/2003 UNDER (72, 75) ADD "SCHWARTZ, DANIEL, M. [US/US]; 42 CALHOUN TERRACE, SAN FRANCISCO, CA 94133 (US)."

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP